SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.120+4.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John F Beule who wrote (580)11/20/1998 8:22:00 AM
From: Anthony Wong  Read Replies (2) of 2539
 
John, international clinical trials are under way to evaluate whether the Cox-2 drugs are effective in colon cancer and Alzheimer's disease. In Alzheimer's, as the brain ravages neurons in the brain, the damage causes inflammation, which in turn causes further damage to surrounding tissues and cells. If Cox-2 inhibitors would reduce inflammation in the brain, the theory is that more brain tissue would be spared.

I don't know how far the trials have progressed. Since you saw the news flash, perhaps there's a paper published/to be published shortly, or just Super Aspirin Fever heating up.

Anthony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext